Consumer Medicine Information
What is in this leaflet
This leaflet answers some common questions about INTEGRILIN.
It does not contain all of the available information.
It does not take the place of talking to your doctor or hospital pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you taking
INTEGRILIN against the benefits it is expected to have for you.
If you have any concerns about using this medicine, ask your doctor or hospital pharmacist.
Keep this leaflet.
You may want to read it again.
What INTEGRILIN is used for
INTEGRILIN works by helping to prevent blood clots by stopping the platelets in the
blood from sticking together.
INTEGRILIN is used in people with unstable angina (chest pain) to help prevent heart
attack and possible death.
Angina is a pain or uncomfortable feeling in the chest, often spreading to the arms
or neck and sometimes to the shoulders and back. This may be caused by too little
blood and oxygen getting to the heart.
INTEGRILIN is also used to prevent the formation of blood clots when people have a
surgical procedure (percutaneous coronary intervention) to open an artery and insert
a tube (stent).
Your doctor, however, may prescribe INTEGRILIN for another purpose.
Ask your doctor if you have any questions about why INTEGRILIN has been prescribed
There is no evidence that INTEGRILIN is addictive.
Before you are given INTEGRILIN
When it must not be given
Do not use INTEGRILIN if:
1. you are allergic to any ingredients listed at the end of this leaflet.
2. you have any of these medical conditions:
a blood clotting disorder or a very low platelet count
a bleeding disorder or you tend to bleed easily
very high blood pressure
severe liver problems or you require dialysis
3. you have had any of these medical conditions:
any internal bleeding (except for menstrual bleeding) in the last month, such as from
an ulcer or blood in the urine or bowel motions
a stroke as a result of bleeding in the brain
any other stroke in the last month
surgery or severe injury in the last six weeks
any brain tumour or a condition that affects the blood vessels around the brain
4. your doctor is going to use either of the following types of medicines:
another injection of the same type as INTEGRILIN
medicines used to destroy or dissolve blood clots
INTEGRILIN should not be used in children.
If you are not sure if you should use INTEGRILIN, contact your doctor or hospital
Before you start to use it
You must tell your doctor if:
you have any other medical conditions including liver or kidney problems or problems
with bleeding or blood clots.
You are pregnant or planning to become pregnant.
Do not use INTEGRILIN if you are pregnant unless you and your doctor have discussed
the risks and benefits involved.
If you are breastfeeding, stop breastfeeding while you are being treated with INTEGRILIN.
Taking other medicines
Tell your doctor if you are taking any medicines to thin your blood, to prevent blood
clots or to dissolve clots.
Tell your doctor if you are taking any other medicines, including aspirin or other
medicines that you buy without a prescription from a pharmacy, supermarket or health
Your doctor will usually give you aspirin or heparin at the same time as INTEGRILIN.
How to use INTEGRILIN
INTEGRILIN is given in hospital by an injection into a vein followed by an intravenous
drip (infusion). The infusion usually lasts for up to 3 or 4 days.
The dose given is based on your weight. Your doctor or hospital pharmacist will work
out the correct dose for you.
You may also be given aspirin and heparin.
If you get too much (overdose)
If you get too much INTEGRILIN, it could cause bleeding. If this happens the intravenous
drip may need to be stopped. Usually, this will be enough to handle the overdose.
However, if necessary, a blood transfusion may be given.
Contact the Poisons Information Centre for advice regarding management of overdose.
In Australia telephone 13 11 26. In New Zealand telephone 0800 POISON or 0800 764
Tell your doctor, nurse or hospital pharmacist as soon as possible if you do not feel
well while you are being given INTEGRILIN.
Like other medicines, INTEGRILIN may cause some side effects. Although not all of
these side effects may occur, if they do occur they may need medical attention.
The most common side effect experienced by people using this medicine is:
While INTEGRILIN is being used, you will be checked for any signs of unusual or unexpected
INTEGRILIN may also cause stinging or redness at the site of injection.
During the administration of INTEGRILIN, the following effects have also occurred
in some patients:
low blood pressure
abnormal fast heart beat
congestive heart failure (disease of the heart with shortness of breath or swelling
of the feet or legs due to build-up of fluid)
swelling and tenderness around a vein
low number of platelets in blood
decreased blood flow to brain
general body pain
It is not possible to know whether these effects are related to INTEGRILIN or to the
condition INTEGRILIN is used to treat. However, these effects can occur in this condition
even without the use of INTEGRILIN.
Other side effects not listed above may also occur in some patients.
If you notice any other effects, check with your doctor.
Ask your doctor or hospital pharmacist any questions you may have.
INTEGRILIN is stored in a hospital.
It should be stored refrigerated at 2°C to 8°C. Do not freeze. It should be protected
from light until administration.
What it looks like
INTEGRILIN is a clear colourless liquid for injection. It comes in vials in two strengths:
INTEGRILIN (eptifibatide 20mg in 10mL) Injection
INTEGRILIN (eptifibatide 75mg in 100mL) Infusion
Eptifibatide (as eptifibatide acetate)
water for injections
Merck Sharp & Dohme (Australia) Pty Limited
Level 1, Building A, 26 Talavera Road,
Macquarie Park NSW 2113,
Merck Sharp & Dohme
(New Zealand) Limited
PO Box 99 851
Australian Registration Number
AUST R 71540 (20mg in 10mL)
AUST R 71541 (75mg in 100mL)
Date of preparation
This leaflet was prepared in July 2020.